Efficacy and safety of (Sacubitril-Valsartan) Combination on Patients With congestive Heart Failure

Safety and Efficacy of Sacubitril/Valsartan Early Initiation in Hospitalized Patients with Heart Failure and Reduced Ejection Fraction

Impact of Sacubitril–Valsartan Treatment on Diastolic Function and Right Ventricular Function in Patient with Heart Failure with Reduced Ejection Fraction

Impact of Sacubatril/Valsartan on Myocardial and Hepatic Stiffness in Heart Failure patients with Reduced Ejection Fraction (HFrEF)

IMPACT OF SACUBITRIL/VALSARTAN COMBINATION ON PREVALENCE OF ARRHYTHMIA IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

Role of Echocardiography in Evaluation of the Effects of Sacubitril–Valsartan on Vascular Stiffness in Patients with Heart Failure: Review Article

Effect of eplerenon on heart failure in patients with paroxysmal Atrial Fibrillation and ejection fraction ≥ 45%.

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

EFFECT OF MODERN VERSUS STANDARD OF CARE ANTI-FAILURE MEDICATIONS ON LEFT VENTRICULAR FUNCTION IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AS DETECTED BY2D SPECKLE TR

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients